Clinicopathological analysis of primary intestinal diffuse large B‐cell lymphoma: Prognostic evaluation of CD5, PD‐L1, and Epstein‐Barr virus on tumor cells

BACKGROUND: Primary intestinal diffuse large B‐cell lymphoma (iDLBCL) is rare. In this study, we investigated the clinicopathological features of this disease to further understand the prognostic value of CD5, programmed cell death ligand 1 (PD‐L1), and Epstein‐Barr virus (EBV) on tumor cells. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, Eri, Kato, Seiichi, Shimada, Kazuyuki, Tanaka, Tsutomu, Suzuki, Yuka, Satou, Akira, Kohno, Kei, Sakakibara, Ayako, Yamamura, Takeshi, Nakamura, Masanao, Miyahara, Ryoji, Goto, Hidemi, Nakamura, Shigeo, Hirooka, Yoshiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308116/
https://www.ncbi.nlm.nih.gov/pubmed/30449068
http://dx.doi.org/10.1002/cam4.1875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308116/
https://www.ncbi.nlm.nih.gov/pubmed/30449068
http://dx.doi.org/10.1002/cam4.1875

Ejemplares similares